Sanofi Agrees to Settle US Antitrust Case Over Lantus
Sanofi reached a tentative settlement of long-running claims by drug wholesalers alleging it used an improper patent listing to suppress competition for its diabetes treatment Lantus.
By Nate RaymondSanofi EURONEXT:SAN has reached a tentative settlement to resolve long-running claims by drug wholesalers that the pharmaceutical company used an improper patent listing to suppress competition to its diabetes treatment Lantus.Lawyers for a group of drug purchasers told a federal jud…